📰 Development Expense News
Page 12 - Development Expense News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Expense. Real-time updates on events, politics, business and more.
March 30, 2023
Statements in the following discussion and throughout this report that are not historical in nature are forward-looking statements. You can identify forward-looking statements by the use of words such... | March 30, 2023
March 30, 2023
Forward-Looking Statements The following section of this Annual Report on Form 10-K entitled Managements Discussion and Analysis of Financial Condition and Results of Operations contains statements... | March 30, 2023
March 29, 2023
Operating leases 2.92 Weighted... | March 29, 2023
March 29, 2023
29.03.2023 - Generated record total revenues of $73.7 million for the full year 2022 Completed enrollment in Phase 3 clinical program evaluating DFD-29 for the treatment of papulopustular rosacea; topline data are expected in the first half of 2023 Company to ...
March 28, 2023
Unless the context otherwise requires, all references in this section to the Company, we, us, or our refer to the business of indie and its subsidiaries prior to the consummation of the Transaction.... | March 28, 2023
March 28, 2023
The following discussion and analysis of the financial condition and results of operations of GreenLight Biosciences Holdings PBC and its consolidated subsidiaries should be read together with the... | March 28, 2023
March 14, 2023
Achieves record revenue of $45 million and annual recurring revenue of $157 million...
March 8, 2023
08.03.2023 - KING OF PRUSSIA, Pa., March 08, 2023 (GLOBE NEWSWIRE) - Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended ...
March 5, 2023
Artificial intelligence is a good place to search for long-term compounding machines.
March 2, 2023
$ million Gross to Net Adjustment 19% - 20% 21% - 21.5% Conference Call Puma Biotechnology will host a conference call to report its fourth quarter and full year 2022 financial results... | March 2, 2023